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ABSTRACT
Sodium carboxymethylcellulose (SCMC) is widely used in the design o f wound 
dressing owing to its high water bonding capacity, good compatibility with skin and 
mucous membrane, biocompatibility and abundant availability at a low cost. This 
study aims to design drug-free (low (LV), medium (MV) and high molecular weight 
(HV)) SCMC scaffolds and promote their ability to promote partial thickness bum 
wound healing via wound moist regulation and microbial burden control. In addition, 
SCMC scaffolds o f distinct wound healing ability is incorporated with y-tocotrienol as 
antioxidant therapeutic and has its wound healing property assessed against pure 
tocopherol and tocotrienol. SCMC scaffolds were prepared by means o f solvent 
evaporation technique and their physicochemical properties namely, in vitro erosion, 
moisture affinity, morphology, tensile strength, polymer molecular weight and 
carboxymethyl substitution were investigated against partial thickness bum wound. 
The transepidermal water loss (TEWL) from wound o f rats treated by control > HV 
scaffold > LV -  MV scaffold. HV scaffold possessed the highest tensile strength of all 
matrices and was resistant to erosion in simulated wound fluid. In spite of constituting 
small nanopores, it afforded a substantial TEWL than MV and LV scaffolds from 
wound across an intact matrix through its low moisture affinity characteristics. HV 
scaffold was also found to protect moisture loss with minimal accumulation at wound 
bed thus promoted reepithelialisation process. Transepidermal water movement 
wound healing by scaffolds was governed by SCMC molecular weight instead o f its 
carboxymethyl substitution degree or matrix pore size distribution. In infected partial 
thickness wound, in vitro polymer characteristics, microstructure, gelling, 
bioadhesiveness, microbial inhibitory, in vivo microbe-colonized wound healing, 
microbe removal and infection control properties were examined against Gram 
positive Staphylococcus aureus and Gram negative Pseudomonas aeruginosa. P. 
aeruginosa was removed via gelling action of LV scaffold which encapsulated 
microbes possibly with the binding aid of their extracellular by-product. S. aureus 
was removed via HV scaffolds ability to crease into multiple tight folds to 
accommodate the microbes under compression and retarded its growth. SCMC 
scaffolds promoted healing via physical attachment and removal from wound bed 
which was generally aided via high polymeric carboxymethyl substitution degree and 
subseqeuent increased o f bioadhesive property of the scaffolds. The HV-PVP 
scaffolds served as the vehicle of y-tocotrienol. The vitamin incorporation was 
characterised by drug content of 91.238 ± 0.137 %. The instantaneous vitamin release 
from the carrier may affect the initial wound healing process as bi-mechanisms of 
modulating the transepidermal water loss contributed by the HV-PVP carrier and 
antioxidant activity of y-tocotrienol. The used of HV-PVP scaffold as the carrier for 
y-tocotrienol deemed to optimize its delivery to the wounded area and showed 
promising outcome in wound healing process.
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CHAPTER ONE 
INTRODUCTION
1.1 OVERVIEW
1.1.1 Wound
Wound is defined as an injury with disruption of the normal continuity o f the 
body structures [1]. There are several types of wounds: contused wound, incised 
wound, lacerated wound, open wound, penetrating wound, perforating wound, 
puncture wound and bum wound. Wounds can be classified as chronic as well as 
acute wounds. The causes o f wound injury include: 1) physical agents such as trauma, 
extremes of temperatures, radiation and electric shock and 2) chemical agents such as 
asbestos, carbon monoxide and insecticides [2].
Acute wound refers to injury which occurs secondary to surgery or trauma in 
an individual [3]. It is characterised by a fast healing rate with complete recovery of 
the injury. Chronic wound is affected by factors which bring about disruption to the 
normal, controlled inflammatory phase or cellular proliferative phase o f an injury that 
may delay the healing process [3, 4], It can be defined as a loss in tissue integrity 
produced through frequent recurrence and/or over an extended duration. Pressure 
ulcer, diabetic ulcer, lower leg ulcer, vascular ulcer, post-operative open wound, and 
entero-cutaneous fistulae are the common examples of chronic wounds [5]. These 
types of wound are approached differently in terms o f treatment to optimise the 
healing process.
1.1.2 Wound Healing
Wound is characterized by skin losses its physical integrity thus exposing the 
tissue to the immediate environment with an excessive loss of water [4, 6, 7]. Wound 
healing is a prompt response that preserves and maintains the integrity o f an organ 
suffering tissue loss. It is a dynamic process which encompasses three overlapping 
phases namely inflammation, proliferation and remodeling (Figure 1.1). These 
sequential phases originate from the interaction and responses of cells in parallel with
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